| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/06/2003 | WO2003010160A2 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010130A1 Amino acid derivatives |
| 02/06/2003 | WO2003009848A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2003009845A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 02/06/2003 | WO2002096420A3 Method for treating nerve injury caused by surgery |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002056016A3 Method for identifying a ligand for a biological substrate |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | US20030028035 By reacting the corresponding NH-amides with acetylenes in the liquid phase using a basic alkali metal compound as catalyst and as cocatalyst (di- or tri-)1,4-butanediol mono- and diethers; N-vinyl-2-pyrrolidone from pyrrolidone |
| 02/06/2003 | US20030028031 Resolution of the enantiomers of amlodipine |
| 02/06/2003 | US20030028029 Process for production of piperidine derivatives |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030027822 Sodium channel modulators |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | US20030027810 Nicotine receptor ligands |
| 02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 02/06/2003 | US20030027795 N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2448722A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 02/06/2003 | CA2399583A1 Novel solvate and crystalline forms of lercanidipine hydrochloride |
| 02/06/2003 | CA2380202A1 Novel crude and crystalline forms of lercanidipine hydrochloride |
| 02/05/2003 | WO2002014280A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280800A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 |
| 02/05/2003 | EP1280775A1 TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS |
| 02/05/2003 | EP1280765A2 Fluorous tagging compounds and their use |
| 02/05/2003 | EP1280528A2 R-eliprodil for treating glaucoma |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394853A Levobubikain carbonate and its preparation |
| 02/05/2003 | CN1100757C Proces for preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetramethylpyridine N-oxide |
| 02/05/2003 | CN1100535C Pharmaceutical agents for treatment of emesis |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515131 Imaging mammal brain tissue via administering technetium, piperidine derivative complex |
| 02/04/2003 | US6515130 The invention relates to a process of preparing (S-(R*,S*))-beta -(((1-(1-oxo-3-(4-piperidinyl)propyl)-3-piperidinyl) carbonyl)amino)-3-pyridinepropanoic acid derivatives represented by the antagonists of the platelet fibrinogen |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6514999 A substance which increases Dopamine concentration in the synaptic cleft of the neurons of the brain, in combination with an effective amount of a local anesthetic of the anilide group or derivatives thereof |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/30/2003 | WO2003008382A1 Method for preparing 4-amino-4-phenylpiperidines |
| 01/30/2003 | WO2003008381A1 Method for preparing 4-methylamino-4-phenylpiperidine |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2002047679A8 Nonpeptide agonists and antagonists of vasopressin receptors |
| 01/30/2003 | WO2001093849A3 Treatment of gastroesophageal reflux disease using piperidine derivatives |
| 01/30/2003 | US20030022922 Tablet, without excessive stickiness or tablet punch residue |
| 01/30/2003 | US20030022919 Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 01/30/2003 | US20030022900 Compositions comprising alpha-1C specific compounds |
| 01/30/2003 | US20030022893 Hydroxamic and carboxylic acid derivatives |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | US20030021849 Polymorphs of fexofenadine hydrochloride |
| 01/30/2003 | US20030020603 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system |
| 01/30/2003 | CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | CA2450365A1 Process for preparing 4-amino-4-phenylpiperidines |
| 01/30/2003 | CA2450362A1 Method for preparing 4-methylamino-4-phenylpiperidine |
| 01/29/2003 | EP1279519A2 Image forming material and ammonium compound |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | EP1278736A1 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals |
| 01/29/2003 | EP1278733A1 Process for the preparation of sterically hindered aryloxyamines |
| 01/29/2003 | EP1278732A1 1-aroyl-piperidinyl benzamidines |
| 01/29/2003 | EP1278731A1 Cyclic quaternary ammonium compounds |
| 01/29/2003 | EP1278730A2 4-benzyl-1- 2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol |
| 01/29/2003 | EP1278729A1 Benzosuberonylpiperidine compounds as analgesics |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP1278726A1 Method for producing cyclic lactams |
| 01/29/2003 | EP1278712A2 Nitroaromatic solubilizer for nitroxyls in aromatic solvents |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP0888319B1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1394201A Substituted glutarimides and use thereof IL-12 production inhibitors |
| 01/29/2003 | CN1100038C Separation of Amlodipine antimer |
| 01/28/2003 | US6511993 Metalloprotease inhibitors |
| 01/28/2003 | US6511992 For treating pain or memory deficiencies related to Alzheimer's disease and other neurodegenerative disorders associated with aging |
| 01/28/2003 | US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
| 01/28/2003 | CA2148839C Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 01/27/2003 | WO2002010127A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 01/27/2003 | CA2417427A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 01/23/2003 | WO2003007071A2 Novel nonlinear optical compounds and polymers |
| 01/23/2003 | WO2003007070A1 Novel nonlinear optical polymers incorporating amines |
| 01/23/2003 | WO2003007069A2 Novel nonlinear optical polymers |
| 01/23/2003 | WO2003006444A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003005962A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 01/23/2003 | WO2002055491A3 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 01/23/2003 | WO2002053535A3 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 01/23/2003 | WO2002051808A3 Muscarinic antagonists |
| 01/23/2003 | WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |